Therapeutic antibody target validation and screening in vivo

Details for Australian Patent Application No. 2010265934 (hide)

Owner Five Prime Therapeutics, Inc.

Inventors Williams, Lewis T.; Wong, Justin; Zhang, Hongbing

Agent Griffith Hack

Pub. Number AU-A-2010265934

PCT Pub. Number WO2010/151793

Priority 61/220,954 26.06.09 US

Filing date 25 June 2010

Wipo publication date 29 December 2010

International Classifications

A61K 49/16 (2006.01) Preparations for testing

Event Publications

19 January 2012 PCT application entered the National Phase

  PCT publication WO2010/151793 Priority application(s): WO2010/151793

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010265936-K-wire and method for surgical procedures

2010265933-Readily isolated bispecific antibodies with native immunoglobulin format